Public Profile

Boehringer Ingelheim Animal Health USA Inc.

Boehringer Ingelheim Animal Health USA Inc., a subsidiary of the global pharmaceutical company Boehringer Ingelheim, is headquartered in the United States and operates extensively across North America. Founded in 1885, the company has established itself as a leader in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a diverse portfolio that includes vaccines, parasiticides, and therapeutics, Boehringer Ingelheim is renowned for its commitment to research and development, which drives the creation of unique products tailored to enhance animal well-being. The company’s dedication to advancing animal health has positioned it among the top players in the market, achieving significant milestones in veterinary medicine and animal care.

DitchCarbon Score

How does Boehringer Ingelheim Animal Health USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Boehringer Ingelheim Animal Health USA Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Boehringer Ingelheim Animal Health USA Inc.'s reported carbon emissions

Boehringer Ingelheim Animal Health USA Inc. currently does not have available carbon emissions data for the most recent year, nor are there specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on climate change or their strategic approach to reducing carbon emissions. The company may be engaged in broader industry efforts to address climate change, but specific details regarding their emissions or commitments are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Boehringer Ingelheim Animal Health USA Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Boehringer Ingelheim Animal Health USA Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Boehringer Ingelheim Animal Health USA Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Taking Reduction Action?

Similar Organizations

Merial Inc.

US
Animal products nec
Updated about 1 month ago
DitchCarbon Score

Huvepharma N.V.

NL
Chemicals nec
Updated 13 days ago

Zoetis

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Bayer

DE
Chemicals nec
Updated 2 days ago

Merck Animal Health

US
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Boehringer Ingelheim

DE
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers